Incidence
Acoording to United Network for Organ Sharing, 2753 adult LDLT and 1283 pediatric LDLT had been performed in the USA till February 2010.
The most common indication for<unk>  was primary sclerosing cholangitis (37.7%).
Survival rates at 10 years was 70% for LDLT and 64% for DDLT.
For all recipients female gender and primary sclerosing cholangitis were associated with improved survival while dialysis and older recipient/donor age were associated with worse survival.
LDLT recipients had longer total operative time and shorter total ischemia time median 98 minutes vs 487 minutes, than DDLT recipients.
Intraoperative blood transfusion requirements were lower in LDLT compared to DDLT. 
Smaller graft size has higher technical complexity, the graft and patient survival rates of patients with right-liverLDLT are not different from those of patients receiving whole-graft DDLT.
Critically ill adult recipients with advanced liver failure, high MELD scores, and numerous secondary complications have generally been reported to have worse outcomes with this procedure.
Seven donor deaths have been reported till 2010 in the USA and 19 deaths worldwide.
The overall mortality rate of liver<unk>  is of the order of 0.2–0.5%.
The risk associated with left-lobe donation may be lower than that with right-lobe donation.
The incidence of complications in the donor varies in the literature from 9 to 67%, but is likely in the 30% range.
The Adult Living Donor Liver<unk>  Cohort Study reported a donor complication rate of 38%; 21% of donors had one complication and 17% had two or more.
Common complications include:
Biliary leaks beyond postoperative day 7 (9%)
bacterial infections (12%)
incisional hernia (6%)
pleural effusion requiring intervention (5%)
neuropraxia (4%)
reexploration (3%)
wound infections (3%)
Intraabdominal abscess (2%)
Liver transplantation epidemiology and demographics
Cirrhosis epidemiology and demographics
Primary biliary cirrhosis epidemiology and demographics
Hepatocellular carcinoma epidemiology and demographics
Fatty liver epidemiology and demographics
Primary biliary cirrhosis surgery
Hepatocellular carcinoma cost-effectiveness of therapy
Liver mass epidemiology and demographics